Robert LeBoyer
Stock Analyst at Noble Financial
(0.04)
# 4,680
Out of 4,692 analysts
425
Total ratings
28.3%
Success rate
-12.3%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $2.98 | +235.57% | 22 | Aug 14, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $50 | $5.20 | +861.54% | 20 | Aug 13, 2026 | |
| NTRB Nutriband | Reiterated: Buy | $15 | $4.37 | +243.49% | 10 | Aug 12, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.25 | +380.00% | 3 | Aug 11, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $9 | $0.4267 | +2,009.21% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $6.57 | +204.41% | 11 | Aug 10, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $12 | $1.33 | +802.26% | 43 | Aug 7, 2026 | |
| GOVX GeoVax Labs | Reiterated: Buy | $10 | $0.6324 | +1,481.28% | 26 | Jul 29, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $1.75 | +2,471.43% | 17 | Jul 14, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.31 | +968.70% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $14.95 | +201.00% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $1.16 | +762.07% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.9936 | +1,107.73% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.91 | +35.36% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $14.10 | +162.41% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.086 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.592 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.214 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.099 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.71 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $1.10 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.70 | $0.07 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $20 | $2.80 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $27 | $0.0001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $15 | $5.02 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.82 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $14 | $1.62 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.98 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $0.6334 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.00001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.17 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.7911 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.72 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.23 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $32.00 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.49 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.91 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1977 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8135 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.13 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $28.91 | n/a | 2 | Aug 5, 2016 |
Eledon Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $2.98
Upside: +235.57%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $5.20
Upside: +861.54%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $4.37
Upside: +243.49%
NanoViricides
Aug 11, 2026
Reiterated: Buy
Price Target: $6
Current: $1.25
Upside: +380.00%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $9
Current: $0.4267
Upside: +2,009.21%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $6.57
Upside: +204.41%
Ocugen
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $1.33
Upside: +802.26%
GeoVax Labs
Jul 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.6324
Upside: +1,481.28%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $1.75
Upside: +2,471.43%
MAIA Biotechnology
Jul 9, 2026
Reiterated: Buy
Price Target: $14
Current: $1.31
Upside: +968.70%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $14.95
Upside: +201.00%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $1.16
Upside: +762.07%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $0.9936
Upside: +1,107.73%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $5.91
Upside: +35.36%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $14.10
Upside: +162.41%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.086
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.592
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.214
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.099
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $3.71
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $1.10
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.70
Current: $0.07
Upside: n/a
May 14, 2021
Maintained: Buy
Price Target: $20 → $20
Current: $2.80
Upside: n/a
Feb 9, 2021
Maintained: Buy
Price Target: $18 → $27
Current: $0.0001
Upside: n/a
Jan 26, 2021
Maintained: Buy
Price Target: $6 → $15
Current: $5.02
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $2.82
Upside: n/a
Jan 24, 2021
Maintained: Buy
Price Target: $6 → $14
Current: $1.62
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $5.98
Upside: n/a
Dec 24, 2020
Maintained: Buy
Price Target: $6
Current: $0.6334
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.00001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $12.17
Upside: n/a
May 28, 2020
Maintained: Buy
Price Target: $5
Current: $0.7911
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.72
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $5.23
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $32.00
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $10.91
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.1977
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.8135
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.13
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $28.91
Upside: n/a